TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: Contracts For Comparative NMR Imaging studies Awarded To Five Institutions; NCI Staff Honored June 8, 1984
TCL Archive Senate Appropriators Reject President’s $228 Million Increase For Cancer Research; House and Senate Report Language September 18, 2009